Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasudil for RBC ATP Release and Vascular Function
NCT03404843Phase 2Completed
- Sponsor
- Colorado State University
- Start
- Jul 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fasudil in vascular dysfunction, sponsored by Colorado State University. Started Jul 2017; status: completed.
02
Drugs
fasudil
03
Conditions
vascular dysfunction
Beyond the preview
Go deeper on NCT03404843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03404843.